A Case Study in Ion Channel Drug Discovery

David Triggle
Department of Biochemical Pharmacology, School Of Pharmacy And Pharmaceutical Sciences, SUNY, Buffalo
Double click image to enlarge
Set as Cover Image
Chapter Description:
Some of the of ion channel medicinal chemistry and pharmacology are well illustrated in the consideration of the group of drugs often referred to as "calcium channel antagonists" and that is a major group of therapeutically available cardiovascular drugs (hypertension, angina, peripheral vascular disorders and selected arrhythmias).

Previous Image Next Image
Image 1
Some of the of ion channel medicinal chemistry and pharmacology are w...
Image 2
The classification of voltage-gated calcium channels in terms of stru...
Image 3
The L-type class of voltage-sensitive calcium channel is sensitive to...
Image 4
These state-dependent interactions have a number of important therape...
Image 5
A variety of second- and third-generation 1,4-dihydropyridines have e...
Image 6
They exhibit increasing affinity for the vasculature relative to card...
Image 7
The enhanced vascular selectivity for the second-generation nisoldipi...
Image 8
The 1,4-dihydropyridine nucleus is remarkably flexible in conferring ...
Image 9
For three series of 1,4-dihydropyridines differing only in their subs...
Image 10
The correlation between the extent of voltage-dependent binding and v...
Image 11
Accordingly, differences in properties DO exist between the first-, s...
Image 12
So can drugs be developed for these calcium channel types that might ...
Image 13
What do we learn from the story of the L-type calcium channel blocker...
Image 14
Can we discover drugs for the non-L channels that will be as successf...
Image 15
Targets that have bee explored for possible uses of drugs active at N...
Image 16
Diminishing returns in drug discovery
Image 17
Mibefradil (Posicor) was a novel calcium channel blocker introduced b...
Image 18
Structure of Mibefradil.
Image 19
General properties of Mibefradil.
Image 20
Although the drug was withdrawn it have (apart from its drug interact...
Image 21
We need a good, potent and selective T-channel blocker!!!!
Image 22
The general structure of the conotoxins – disulphide–bridged pept...
Image 23
These toxins which interact with the N-type channel are effective in ...
Image 24
Drugs that interact at N-type channels may have multiple (and potenti...
Image 25
Molecules that interact with calcium channels by new routes. Gabapen...
Image 26
Image 27
Thirty years of failure!!!
Image 28
Image 29
Is it possible that for some diseases we need drugs that have multipl...
Image 30
Image 31
Image 32
Targets of potential interest for the development of new calcium chan...
Image 33
And ........it helps to have a champion -someone who really believes...
 
  • Comments
  • Description
   
Sign up to Add Comment!
 
Characters Left :
Bag Bag
Anyahind March replica handbagsBally replica handbagsBalenciaga replica handbagsBottega Veneta replica hand
1 year ago
Delete
Watchesreplica Watchesreplica
Croum replicaChopard replicaCartier replicaConcord replicaDeWitt replicaDior replica
1 year ago
Delete
Rocky Zeng
a few seconds of video, Dior Jewelry glimpsed one of the medevaced jaeger lecoultre master calendar soldier's hands and knew it christian dior watch was Stephan. She connected w
1 year ago
Delete
Jason Bourne
Our christian louboutin sale online store recommand. To be a sexy and charming lady from wearring christian louboutin shoes.
1 year ago
Delete
Edwin Jesas
Medical Center 000-180 earned a spot 000-217 on the "America's Best Hospitals Honor Roll" 000-232, ranking among the top 21 hospitals in the nation 000-258.
1 year ago
Delete
Edwin Jesas
Hope to see some more cool stuff.cheap coldfusion hosting|cheap asp hosting
2 years ago
Delete
Edwin Jesas
Great Case Study in Ion Channel Drug Discovery.colocation server hosting|cheap windows hosting
2 years ago
Delete
Triple Hhh
His contributions to these expeditions earned him three Polar Medals, ||640-802 testking||000-377||000-965||117-201||
2 years ago
Delete
  
    Brief Description
 
The group of drugs known as the “calcium channel blockers” or “calcium channel antagonists” provide an interesting case study from two perspectives: 1. As a mature group of therapeutics agents why are they cardiovascular selective? 2. Given that there are several classes of voltage-gated calcium channels why has it been so difficult to find blockers active at the non-L-type channels?

 
    Full Description
 
 
    Citation
 
 
    Abstract
 
 
    Introduction
 
 
    Results
    Discussions
 
 
    Material Methods
 
 
    References
 
 
 
 
Stats
 
Publish date Views Ref#
Jun 02, 2009 1886 VA:06:02:676:2009
 
Rating
   
 
Your rating: None Average: 4 (1 vote)
 
Embed Code
 
Files